Our Press Releases | Association for Accessible Medicines

In the News - AAM CEO Dan Leonard shares the industry's 2021 outlook with Chain Drug Review.

American flag waving against blue sky

Jun 18, 2020 | Rachel Schwartz

AAM Statement on USTR Lighthizer’s House Testimony on USMCA

Facade of the U.S. Capitol building

Jun 2, 2020 | Rachel Schwartz

AAM Statement on Senate Finance Hearing on FDA’s Foreign Manufacturing Inspection Process

Photo of a Court House

May 14, 2020 | Rachel Schwartz

AAM Files Amicus Brief Supporting the BPCIA

Supply Chain Shipping - Medical Supplies

Apr 30, 2020 | Rachel Schwartz

Pharmaceutical Shipping Costs Spike in Response to Global COVID-19 Pandemic

AAM Blueprint Supply Chain Header

Apr 30, 2020 | Rachel Schwartz

AAM Releases Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain

Mar 24, 2020 | Rachel Schwartz

AAM Statement: Preserving Patient Access to Low-Cost Medicines Through COVID-19 and Beyond

Feb 24, 2020 | Rachel Schwartz

AAM and the Biosimilars Council Applaud FDA’s Release of Enhanced Purple Book

Feb 20, 2020 | Rachel Schwartz

Insurers Fail to Get New Generics to America’s Patients

2020 Avalere Analysis Generic Tiers

Feb 13, 2020 | Rachel Schwartz

Avalere Analysis Finds Medicare Part D Patients Are Paying More For Their Lower-Cost Generics

Feb 10, 2020 | Rachel Schwartz

AAM Statement on Resignation of Chip Davis

Feb 6, 2020 | Rachel Schwartz

AAM Announces 2020 Associate Members

Feb 6, 2020 | Rachel Schwartz

AAM Announces 2020 Board of Directors